252 related articles for article (PubMed ID: 12206793)
1. Recombinant micro-genes and dystrophin viral vectors.
Dickson G; Roberts ML; Wells DJ; Fabb SA
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S40-4. PubMed ID: 12206793
[TBL] [Abstract][Full Text] [Related]
2. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.
Fabb SA; Wells DJ; Serpente P; Dickson G
Hum Mol Genet; 2002 Apr; 11(7):733-41. PubMed ID: 11929846
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
Wells DJ; Wells KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
[TBL] [Abstract][Full Text] [Related]
6. Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin.
Scott JM; Li S; Harper SQ; Welikson R; Bourque D; DelloRusso C; Hauschka SD; Chamberlain JS
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S23-9. PubMed ID: 12206791
[TBL] [Abstract][Full Text] [Related]
7. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
8. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
[TBL] [Abstract][Full Text] [Related]
9. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
[TBL] [Abstract][Full Text] [Related]
10. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
11. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for muscular dystrophy].
Takeda S
No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
[TBL] [Abstract][Full Text] [Related]
13. Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.
Banks GB; Chamberlain JS; Odom GL
PLoS Genet; 2020 Nov; 16(11):e1009179. PubMed ID: 33175853
[TBL] [Abstract][Full Text] [Related]
14. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.
Clemens PR; Kochanek S; Sunada Y; Chan S; Chen HH; Campbell KP; Caskey CT
Gene Ther; 1996 Nov; 3(11):965-72. PubMed ID: 8940636
[TBL] [Abstract][Full Text] [Related]
15. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
Dudley RW; Lu Y; Gilbert R; Matecki S; Nalbantoglu J; Petrof BJ; Karpati G
Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
[TBL] [Abstract][Full Text] [Related]
16. Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability.
Gonçalves MA; van Nierop GP; Tijssen MR; Lefesvre P; Knaän-Shanzer S; van der Velde I; van Bekkum DW; Valerio D; de Vries AA
J Virol; 2005 Mar; 79(5):3146-62. PubMed ID: 15709034
[TBL] [Abstract][Full Text] [Related]
17. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
18. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
Perkins KJ; Davies KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.
Matecki S; Dudley RW; Divangahi M; Gilbert R; Nalbantoglu J; Karpati G; Petrof BJ
Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L569-76. PubMed ID: 15155269
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6.
Odom GL; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2011 Jan; 19(1):36-45. PubMed ID: 20859263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
